 HANOVER, MD, Sept. 16, 2021 GLOBE NEWSWIRE -- Processa Pharmaceuticals, Inc. NASDAQ: PCSA, Processa or the Company, a clinical-stage biopharmaceutical company developing products to improve the survival andor quality of life for patients who have unmet medical needs, announced today that management will participate in upcoming investor conferences: 